HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,510
-200 (-1.27%)
At close: Feb 27, 2026
-42.34% (1Y)
| Market Cap | 217.80B -40.1% |
| Revenue (ttm) | 36.10B +75.7% |
| Net Income | 472.66M |
| EPS | 34.13 |
| Shares Out | 14.04M |
| PE Ratio | 460.79 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,727 |
| Average Volume | 193,979 |
| Open | 15,560 |
| Previous Close | 15,710 |
| Day's Range | 15,410 - 15,650 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.48 |
| RSI | 40.55 |
| Earnings Date | Mar 20, 2026 |